The European Commission approved Sanofi and AstraZeneca’s respiratory syncytial virus preventive drug Nov. 4 while the U.S. faces a surge and a lack of RSV treatments.
Read the full post on Becker's Hospital Review - Healthcare News
Europe approves Sanofi’s RSV prevention treatment
